Metastatic Melanoma: Lactate Dehydrogenase Levels and CT Imaging Findings of Tumor Devascularization Allow Accurate Prediction of Survival in Patients Treated with Bevacizumab-Reference-Cited by-同舟云学术

Metastatic Melanoma: Lactate Dehydrogenase Levels and CT Imaging Findings of Tumor Devascularization Allow Accurate Prediction of Survival in Patients Treated with Bevacizumab

Published:2014-02 Issue:2 Volume:270 Page:425-434
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Gray Mark R.,Martin del Campo Sara,Zhang Xu,Zhang Haowei,Souza Frederico F.,Carson William E.,Smith Andrew D.

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.13130776

Reference19 articles.

1. Vemurafenib (PLX4032): An Orally Available Inhibitor of Mutated BRAF for the Treatment of Metastatic Melanoma

2. Final Version of 2009 AJCC Melanoma Staging and Classification

3. Biomarkers in melanoma

4. Preliminary Results of the Combination of Bevacizumab and Weekly Paclitaxel in Advanced Melanoma

5. A Phase 2 Trial of Bevacizumab and High-dose Interferon Alpha 2B in Metastatic Melanoma

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The serum LDH level and KELIM scores are potential predictors of a benefit from bevacizumab first-line therapy for patients with advanced ovarian cancer;Clinical and Translational Oncology;2024-06-21

2. Early Tumor Size Reduction of at least 10% at the First Follow-Up Computed Tomography Can Predict Survival in the Setting of Advanced Melanoma and Immunotherapy;Academic Radiology;2021-06

3. Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities;Frontiers in Oncology;2021-02-04

4. RAGE Signaling in Melanoma Tumors;International Journal of Molecular Sciences;2020-11-26

5. Assessing Immunotherapy with Functional and Molecular Imaging and Radiomics;RadioGraphics;2020-11